Vaccine
🦾 AI has designed an entirely new kind of vaccine for the first time
Ordinary vaccines target a current strain of a virus and quickly become outdated when it mutates. The new method instead makes it possible to design a vaccine that protects against an entire virus family at once.This means the vaccine can provide protection even against future mutations.
🎗️ Now cancer vaccines are coming
The immune system can now be used to treat several types of cancer, and more than 2,500 immunotherapies are in development. Cancer vaccines have also started to show results in clinical trials, against melanoma, pancreatic cancer, and brain tumors, among others.
🦟 Malaria vaccine has reduced child mortality by 13% in three African countries
A study confirms that the RTS,S vaccine has reduced overall child mortality by 13 percent in Ghana, Kenya and Malawi. The effect was achieved even though only 71 percent of children received three doses and 40 percent received the fourth dose.
👩💻 Open source helps reach millions of unvaccinated children
Many countries have long collected vaccination data on paper or in Excel, causing delays and gaps. Now the University of Oslo and Gavi have built digital systems in 40 low- and middle-income countries. The result: hundreds of thousands of children vaccinated – in Mozambique and Kenya alone.
💉 New vaccine reduced Lyme disease cases by 70 percent in clinical trial
Pharmaceutical companies Pfizer and Valneva report that their Lyme disease vaccine LB6V reduced the number of disease cases by around 70 percent compared with placebo. It would become the first approved Lyme disease vaccine for humans in nearly three decades.
🧬 From 13% to 88%: This many survive pancreatic cancer thanks to new vaccine
Pancreatic cancer is one of the deadliest cancers. Fewer than 13 percent of those diagnosed survive more than five years. But after receiving a new mRNA vaccine, nearly 90 percent are still alive six years later.
🪱 Hookworm vaccine reduces infection in trial – could help millions with anemia
Hookworm infects more than 100 million people and is a major cause of iron-deficiency anemia, particularly in children and pregnant women. A phase 2 trial shows that a vaccine candidate substantially reduces the intensity of infection.
🧒 First vaccine that protects children from deadly E. coli infections
ETVAX is the first vaccine to show significant protection against E. coli infections in humans. The vaccine reduced moderate-to-severe diarrhea in infants under nine months by 68 percent. A phase 3 trial with 5,800 infants from low- and middle-income countries is about to begin.
🤧 A single nasal spray vaccine could protect against all coughs, colds and flus
Researchers have developed a "universal vaccine" in the form of a nasal spray that in animal experiments protected against virtually all tested viruses, bacteria and even allergens. The method puts immune cells in the lungs in a heightened state of readiness.